bwge2019 has ended

Create Your Own Event

bwge2019

Belgian Week of Gastroenterology 2019

08:15 CET

Breakfast Symposium ELI LILLY: To triplet or not to triplet: How to optimize sequential treatment in Gastric & GEJ cancer Room TEUNVeerle Casneuf • Marc Van den Eynde • Karen Geboes

09:00 CET

Combining Baseline 18F-FDG PET/CT-based Metabolically Active Tumor Volume and Early Detection of Non-Response Significantly Improves Outcome Prediction in Chemorefractory Metastatic Colorectal Cancer Room TEUNErwin Woff

09:10 CET

Neuroendocrine neoplasms grade 3: prospective overall survival data and survival after platinum-etoposide chemotherapy within an ENETS Center of Excellence Room TEUNAnton Cuypers

09:20 CET

Targeting CD70-positive cancer associated fibroblasts to tackle the immune suppressive tumor microenvironment in colorectal cancer. Room TEUNJulie Jacobs

09:30 CET

Baseline high levels of cell-free DNA and the early increase of at least one mutation are independent prognostic biomarkers for patients with advanced colorectal cancer under regorafenib Room TEUNPashalina Kehagias

09:40 CET

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features Room TEUNFrancesco Puleo

09:50 CET

“NEOPAC”: A multi-centric prospective observational registry on the NEOadjuvant therapeutic approach to the localised PAncreatiC adenocarcimona, a collaborative inter-university project (Ulg – FLCD - UCL... Room TEUNJerome Siplet

10:00 CET

Regorafenib after failure of gemcitabine and platinum-based chemotherapy for locally advanced (non resectable) and metastatic biliary tumors: a randomized double-blinded placebo-controlled phase II trial. Room TEUNAnne DEMOLS

10:10 CET

Preoperative Radiation Therapy With a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: A Multicentric Randomized Study Room TEUNMark DE RIDDER

10:20 CET

Combined Ga-DOTATATE and FDG PET/CT Imaging Improves Prognostic Stratification In Metastatic Gastroenteropancreatic Neuroendocrine Neoplasias. Room TEUNIOANNIS KARFIS

10:30 CET

Efficacy, safety, and patient-reported outcomes in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400ng/ml: A pooled analysis from REACH and REACH-2 studies Room TEUNVinay Ranka